{"log_id": 5423825897022651273, "direction": 0, "words_result_num": 57, "words_result": [{"probability": {"variance": 0.027751, "average": 0.899475, "min": 0.449494}, "location": {"width": 498, "top": 209, "height": 35, "left": 166}, "words": "氯化钙溶液)正性肌力药等、血液旗不能清除维拉糖米"}, {"probability": {"variance": 0.000105, "average": 0.985968, "min": 0.968654}, "location": {"width": 102, "top": 244, "height": 24, "left": 174}, "words": "【药理毒理"}, {"probability": {"variance": 6e-06, "average": 0.997652, "min": 0.993698}, "location": {"width": 79, "top": 273, "height": 23, "left": 203}, "words": "药理作用"}, {"probability": {"variance": 0.005809, "average": 0.964322, "min": 0.695922}, "location": {"width": 866, "top": 287, "height": 42, "left": 203}, "words": "盐酸维拉帕米为钙离子拮抗剂通过调节心肌传导细胞、心肌收缩细胞以及动脉血管平滑肌细胞细胞"}, {"probability": {"variance": 0.00235, "average": 0.986593, "min": 0.7416}, "location": {"width": 530, "top": 322, "height": 34, "left": 165}, "words": "膜上的钙离子内流,发挥其药理学作用,但不改变血清钙浓度"}, {"probability": {"variance": 0.013583, "average": 0.951172, "min": 0.452797}, "location": {"width": 869, "top": 344, "height": 40, "left": 201}, "words": "盐酸维拉帕米扩张心脏正常部位和缺血部位的冠状动脉主干和小动脉,抽抗自发的或光角新碱诱发的"}, {"probability": {"variance": 0.007503, "average": 0.962888, "min": 0.638299}, "location": {"width": 907, "top": 372, "height": 39, "left": 165}, "words": "冠状动脉痉挛,增加了冠状动脉痉挛病人心肌氧的递送,解除和预防冠状动脉痉挛;维拉帕米减少总外周"}, {"probability": {"variance": 0.00095, "average": 0.985144, "min": 0.861166}, "location": {"width": 590, "top": 404, "height": 34, "left": 164}, "words": "阻力,降低心肌耗氧量。可用于治疗变异型心绞痛和不稳定型心绞痛"}, {"probability": {"variance": 0.004768, "average": 0.97827, "min": 0.636008}, "location": {"width": 870, "top": 425, "height": 42, "left": 202}, "words": "维拉帕米减少钙离子内流,延长房室结的有效不应期,减慢传导,可降低慢性心房颤动和心房扑动病"}, {"probability": {"variance": 7.6e-05, "average": 0.995395, "min": 0.95291}, "location": {"width": 907, "top": 452, "height": 42, "left": 165}, "words": "人的心室率:减少阵发性室上性心动过速发作的频率。通常维拉帕米影响正常的实性心率作用较小,但可"}, {"probability": {"variance": 0.006006, "average": 0.983743, "min": 0.468751}, "location": {"width": 904, "top": 480, "height": 41, "left": 166}, "words": "导致病窦综合征病人窦性停搏或窦房阻滞;维拉帕米不改变正常心房的动作电位或室内传导时间,但它降"}, {"probability": {"variance": 0.000234, "average": 0.994659, "min": 0.900968}, "location": {"width": 907, "top": 508, "height": 39, "left": 165}, "words": "低被抑制的心房纤维去极化的振幅、速度以及传导的速度,可能缩短附加旁路通道的前向有效不应期,加"}, {"probability": {"variance": 3.8e-05, "average": 0.996898, "min": 0.966553}, "location": {"width": 627, "top": 539, "height": 36, "left": 166}, "words": "速房室旁路合并心房扑动或心房颤动病人的心室率,甚至会诱发心室颤动"}, {"probability": {"variance": 0.005048, "average": 0.983612, "min": 0.523165}, "location": {"width": 858, "top": 562, "height": 39, "left": 205}, "words": "维拉帕米通过降低体循环的血管阻力产生降低血压作用,一般不引起体位性低血压或反射性心动过速"}, {"probability": {"variance": 0.000267, "average": 0.993007, "min": 0.910825}, "location": {"width": 869, "top": 591, "height": 38, "left": 205}, "words": "维拉帕米减轻后负荷,抑制心肌收缩,可改善左室舒张功能。在心肌等长或动力性运动中,维拉帕米"}, {"probability": {"variance": 9.5e-05, "average": 0.996621, "min": 0.946292}, "location": {"width": 904, "top": 616, "height": 42, "left": 170}, "words": "不改变心室功能正常病人的心脏收缩功能。器质性心脏疾病的病人,维拉帕米的负性肌力作用可被降低后"}, {"probability": {"variance": 0.017936, "average": 0.952106, "min": 0.411363}, "location": {"width": 908, "top": 644, "height": 42, "left": 168}, "words": "负荷的作用抵消,心脏指数无下降。但在严重左室功能不全的病人(例如肺楔压大于20mmHg射血分数小"}, {"probability": {"variance": 0.007316, "average": 0.977443, "min": 0.494277}, "location": {"width": 700, "top": 676, "height": 35, "left": 168}, "words": "于30%),或服用β受体阻滞剂或其心肌抑制药物的病人,可能出现心功能恶化"}, {"probability": {"variance": 0.001832, "average": 0.98727, "min": 0.761143}, "location": {"width": 861, "top": 700, "height": 41, "left": 204}, "words": "动物试验提示维拉帕米的高部作用,是普鲁卡因等摩尔的1.6倍。在人体该作用及剂量尚不清楚"}, {"probability": {"variance": 1.6e-05, "average": 0.996522, "min": 0.987432}, "location": {"width": 221, "top": 736, "height": 30, "left": 204}, "words": "致癌、致突变和生殖毒性"}, {"probability": {"variance": 0.015376, "average": 0.954022, "min": 0.364712}, "location": {"width": 856, "top": 754, "height": 41, "left": 207}, "words": "维拉帕米无致癌性艾姆斯试证实维拉帕米无致突变性。 Beagle狗长期服用维拉帕米≥30mg/Kg/d"}, {"probability": {"variance": 0.002476, "average": 0.982212, "min": 0.833036}, "location": {"width": 241, "top": 792, "height": 27, "left": 171}, "words": "导致透镜状和线状改变"}, {"probability": {"variance": 0.006394, "average": 0.977669, "min": 0.551027}, "location": {"width": 557, "top": 782, "height": 35, "left": 517}, "words": "Kg/d时引起症状明显的白内障。人类尚未有因服用维拉帕米而促"}, {"probability": {"variance": 0.005232, "average": 0.978832, "min": 0.610298}, "location": {"width": 668, "top": 811, "height": 40, "left": 170}, "words": "使白内障形成的道性鼠未见损生殖力。对人类的生殖力影响尚不明确"}, {"probability": {"variance": 2e-06, "average": 0.998741, "min": 0.996064}, "location": {"width": 123, "top": 849, "height": 26, "left": 175}, "words": "【药代动力学"}, {"probability": {"variance": 0.000222, "average": 0.992073, "min": 0.953067}, "location": {"width": 149, "top": 878, "height": 26, "left": 227}, "words": "禁食状态下口服维"}, {"probability": {"variance": 0.000372, "average": 0.992297, "min": 0.911654}, "location": {"width": 656, "top": 864, "height": 37, "left": 420}, "words": "米缓释片生物利用度与维拉帕米普通片剂相似。经门静脉有首过效应,生物"}, {"probability": {"variance": 0.000735, "average": 0.9881, "min": 0.846332}, "location": {"width": 909, "top": 891, "height": 41, "left": 168}, "words": "利用度仅有20%35%。禁食状态下单剂口服维拉帕米缓释片240mg后5.21小时内达峰浓度,血浆峰浓度为"}, {"probability": {"variance": 0.004, "average": 0.968483, "min": 0.717748}, "location": {"width": 895, "top": 921, "height": 41, "left": 172}, "words": "64ng/ml,AUC0~24小时)为1,478nghr/ml餐后用药,达峰时间为7.71小时,血浆峰浓度为79ng/ml"}, {"probability": {"variance": 0.018413, "average": 0.930329, "min": 0.407464}, "location": {"width": 517, "top": 954, "height": 33, "left": 168}, "words": "AUC(0~24小时)为841ng·hr/m血浆蛋白结合率约为90%"}, {"probability": {"variance": 0.000219, "average": 0.99224, "min": 0.946397}, "location": {"width": 853, "top": 974, "height": 40, "left": 222}, "words": "维拉帕米大部分在肝脏代谢。平均半衰期为2.8~7.4小时,在加量期可能延长。长期口服(间隔6小"}, {"probability": {"variance": 0.000531, "average": 0.990519, "min": 0.902957}, "location": {"width": 711, "top": 1003, "height": 40, "left": 168}, "words": "时给药至少10次)半衰期增加至4.5~12.0小时。老年病人的清除半衰期可能延长"}, {"probability": {"variance": 0.006419, "average": 0.976709, "min": 0.449499}, "location": {"width": 867, "top": 1029, "height": 39, "left": 209}, "words": "口服维拉帕米后5天内大约70%以代谢物由尿中排泄,16%或更多由粪便清除,约3%~4%以原型由尿排"}, {"probability": {"variance": 6.4e-05, "average": 0.996264, "min": 0.954111}, "location": {"width": 907, "top": 1055, "height": 42, "left": 169}, "words": "出。尿中可检测到13种代谢产物:除去甲维拉帕米外,所有代谢产物都是微量的。去甲维拉帕米的心血管"}, {"probability": {"variance": 3.4e-05, "average": 0.997514, "min": 0.968346}, "location": {"width": 587, "top": 1088, "height": 35, "left": 169}, "words": "活性是维拉帕米的20%可达到与维拉帕米基本相同的稳态血药浓度"}, {"probability": {"variance": 0.000248, "average": 0.994891, "min": 0.895951}, "location": {"width": 870, "top": 1110, "height": 42, "left": 207}, "words": "维拉帕米在肝功能不全的病人代谢延迟,清除半衰期延长至14~16小时,表观分布容积增加,血浆清"}, {"probability": {"variance": 7e-06, "average": 0.998161, "min": 0.989909}, "location": {"width": 278, "top": 1147, "height": 32, "left": 167}, "words": "除率降低至肝功能正常人的30%"}, {"probability": {"variance": 0.005088, "average": 0.956912, "min": 0.833427}, "location": {"width": 106, "top": 1181, "height": 23, "left": 176}, "words": "【贮藏】"}, {"probability": {"variance": 0, "average": 0.999042, "min": 0.998464}, "location": {"width": 79, "top": 1209, "height": 23, "left": 209}, "words": "密封保存"}, {"probability": {"variance": 0, "average": 0.99938, "min": 0.998462}, "location": {"width": 106, "top": 1236, "height": 24, "left": 178}, "words": "【包装】"}, {"probability": {"variance": 4.9e-05, "average": 0.996429, "min": 0.974831}, "location": {"width": 184, "top": 1262, "height": 27, "left": 210}, "words": "塑料瓶,30片/瓶/盒"}, {"probability": {"variance": 0.001435, "average": 0.980454, "min": 0.904691}, "location": {"width": 109, "top": 1291, "height": 25, "left": 174}, "words": "【有效期】"}, {"probability": {"variance": 0.005685, "average": 0.955914, "min": 0.825323}, "location": {"width": 67, "top": 1320, "height": 23, "left": 209}, "words": "36个月"}, {"probability": {"variance": 3e-06, "average": 0.998374, "min": 0.9959}, "location": {"width": 106, "top": 1347, "height": 23, "left": 178}, "words": "【执行标准】"}, {"probability": {"variance": 0.000472, "average": 0.991804, "min": 0.915218}, "location": {"width": 239, "top": 1368, "height": 34, "left": 218}, "words": "《中国药典》2010年版二部"}, {"probability": {"variance": 0.001218, "average": 0.983182, "min": 0.90523}, "location": {"width": 109, "top": 1402, "height": 24, "left": 176}, "words": "【批准文号】"}, {"probability": {"variance": 0.000268, "average": 0.989646, "min": 0.936674}, "location": {"width": 174, "top": 1428, "height": 27, "left": 211}, "words": "国药准字H10920017"}, {"probability": {"variance": 7e-06, "average": 0.998252, "min": 0.992387}, "location": {"width": 104, "top": 1457, "height": 23, "left": 179}, "words": "【生产企业】"}, {"probability": {"variance": 1.8e-05, "average": 0.997795, "min": 0.983187}, "location": {"width": 339, "top": 1479, "height": 33, "left": 212}, "words": "企业名称:江苏恒瑞医药股份有限公司"}, {"probability": {"variance": 0.056514, "average": 0.797427, "min": 0.463652}, "location": {"width": 131, "top": 1459, "height": 51, "left": 552}, "words": "医药为"}, {"probability": {"variance": 0.001319, "average": 0.984345, "min": 0.854672}, "location": {"width": 380, "top": 1505, "height": 35, "left": 213}, "words": "生产地址:连云港市新浦区人民东路145号"}, {"probability": {"variance": 0, "average": 0.834236, "min": 0.834236}, "location": {"width": 40, "top": 1490, "height": 40, "left": 672}, "words": "会"}, {"probability": {"variance": 3e-06, "average": 0.997983, "min": 0.993456}, "location": {"width": 157, "top": 1541, "height": 23, "left": 212}, "words": "邮政编码:222002"}, {"probability": {"variance": 0.013412, "average": 0.961678, "min": 0.393641}, "location": {"width": 333, "top": 1565, "height": 29, "left": 212}, "words": "电话号码:800-8283900400-828390"}, {"probability": {"variance": 0.012142, "average": 0.956941, "min": 0.628546}, "location": {"width": 235, "top": 1596, "height": 24, "left": 212}, "words": "传真号码:0518-85453849"}, {"probability": {"variance": 0.000396, "average": 0.988668, "min": 0.932503}, "location": {"width": 167, "top": 1624, "height": 23, "left": 213}, "words": "网址:http://"}, {"probability": {"variance": 6e-05, "average": 0.989674, "min": 0.979868}, "location": {"width": 211, "top": 1593, "height": 74, "left": 500}, "words": "质管部"}], "language": 3}